These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9741502)

  • 21. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
    Topol EJ; Califf RM; Vandormael M; Grines CL; George BS; Sanz ML; Wall T; O'Brien M; Schwaiger M; Aguirre FV
    Circulation; 1992 Jun; 85(6):2090-9. PubMed ID: 1591828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction.
    Nabel EG; Topol EJ; Galeana A; Ellis SG; Bates ER; Werns SW; Walton JA; Muller DW; Schwaiger M; Pitt B
    J Am Coll Cardiol; 1991 Feb; 17(2):467-73. PubMed ID: 1825097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for acute myocardial infarction.
    Kereiakes DJ; Topol EJ; George BS; Abbottsmith CW; Stack RS; Candela RJ; O'Neill WW; Martin LH; Califf RM
    J Am Coll Cardiol; 1988 May; 11(5):899-907. PubMed ID: 2965716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.
    Goodman S; Hill C; Bata I; Fung A; Higginson L; Lam J; Massel D; McCans J; Nasmith J; Stanton E; Thompson C; Warnica W; Langer A
    Can J Cardiol; 1996 Nov; 12(11):1183-90. PubMed ID: 9191511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS).
    Neuhaus KL; von Essen R; Tebbe U; Vogt A; Roth M; Riess M; Niederer W; Forycki F; Wirtzfeld A; Maeurer W
    J Am Coll Cardiol; 1992 Apr; 19(5):885-91. PubMed ID: 1552106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage.
    Haider AW; Andreotti F; Hackett DR; Tousoulis D; Kluft C; Maseri A; Davies GJ
    J Am Coll Cardiol; 1995 Sep; 26(3):662-7. PubMed ID: 7642856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of early reperfusion and prediction of left ventricular damage from the course of increased ST values in acute myocardial infarct with thrombolysis].
    Dissmann R; Goerke M; von Ameln H; Rennhak U; Schroeder J; Linderer T; Schröder R
    Z Kardiol; 1993 May; 82(5):271-8. PubMed ID: 8328176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of reinfarction subsequent to non-Q-wave infarction.
    Roberts R; Gibson RS
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S36-46. PubMed ID: 2468975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC; Reiter RJ; Jimenez-Sosa A
    Contemp Clin Trials; 2007 Jul; 28(4):532-9. PubMed ID: 17123867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
    J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.
    Wallentin L; Bergstrand L; Dellborg M; Fellenius C; Granger CB; Lindahl B; Lins LE; Nilsson T; Pehrsson K; Siegbahn A; Swahn E
    Eur Heart J; 2003 May; 24(10):897-908. PubMed ID: 12714021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
    Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
    Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous SM-9527 (double-chain tissue plasminogen activator) on left ventricular function in the chronic stage of acute myocardial infarction.
    Hayashi H; Takatsu F; Sone T; Mizutani N; Hirayama H; Osugi J; Yamauchi K; Ogawa H; Watanabe T; Saito H
    Clin Cardiol; 1993 May; 16(5):409-14. PubMed ID: 8504575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
    Hackett D; Andreotti F; Haider AW; Brunelli C; Shahi M; Fussell A; Buller N; Foale R; Lipkin D; Caponnetto S
    Am J Cardiol; 1992 Jun; 69(17):1393-8. PubMed ID: 1590225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
    Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
    J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.